Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 50,762 $ 86,411
Restricted cash 3,825 5,650
Inventory 24,546 28,776
Prepaid expenses and other current assets 2,708 3,359
Total current assets 81,841 124,196
Restricted cash 1,002 2,802
Property and equipment, net 5,987 11,625
Operating lease right-of-use assets 13,622 9,612
Other long-term assets 2,741 2,507
Total assets 105,193 150,742
Current liabilities:    
Accounts payable 9,668 8,074
Accrued expenses 11,550 16,020
Deferred revenue 6,770 7,154
Debt, current 10,000 0
Operating lease liabilities, current 1,205 3,489
Other current liabilities 393 306
Total current liabilities 39,586 35,043
Debt, noncurrent 22,166 71,662
Operating lease liabilities, noncurrent 13,588 14,404
Derivative liabilities 3,491 11,511
Total liabilities 78,831 132,620
Commitments and contingencies (Note 6)
Redeemable convertible preferred stock, $0.0001 par value — 100,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 25,000 and 10,000 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 24,842 10,000
Stockholders’ equity:    
Common stock, $0.0001 par value — 600,000,000 Class A shares authorized as of September 30, 2024 and December 31, 2023; 33,899,853 and 32,183,695 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively; 200,000,000 Class B shares authorized as of September 30, 2024 and December 31, 2023; 5,451,863 and 5,724,199 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 4 4
Additional paid-in capital 637,394 629,208
Accumulated deficit (635,878) (621,090)
Total stockholders’ equity 1,520 8,122
Total liabilities, redeemable convertible preferred stock and stockholders’ equity $ 105,193 $ 150,742